CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Concurrent, Prolonged Use of Bedaquiline and Delamanid for Multidrug-Resistant Tuberculosis
Dong-gon Hyun, Se hee Lee, Kyung-Wook Jo, Tae Sun Shim
Korean J Med. 2019;94(3):294-298.   Published online 2019 May 31    DOI: https://doi.org/10.3904/kjm.2019.94.3.294

Excel Download

Concurrent, Prolonged Use of Bedaquiline and Delamanid for Multidrug-Resistant Tuberculosis
The Korean Journal of Medicine. 2019;94(3):294-298   Crossref logo
Link1 Link2 Link3

Erratum: Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea
Annals of Laboratory Medicine. 2019;39(1):113   Crossref logo
Link1 Link2 Link3

Combining bedaquiline and delamanid to treat multidrug-resistant tuberculosis
The Lancet Infectious Diseases. 2018;18(5):480-481   Crossref logo
Link1 Link2

Bedaquiline and delamanid in the treatment of multidrug‐resistant tuberculosis: Promising but challenging
Drug Development Research. 2018;   Crossref logo
Link1 Link2 Link3

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review
International Journal of Molecular Sciences. 2017;18(2):341   Crossref logo
Link1

Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB)
Tuberculosis. 2018;111:20-30   Crossref logo
Link1 Link2

Profile of delamanid for the treatment of multidrug-resistant tuberculosis
Drug Design, Development and Therapy. 2015;677   Crossref logo
Link1

Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea
Annals of Laboratory Medicine. 2018;38(6):563   Crossref logo
Link1 Link2 Link3

Delamanid in multidrug-resistant tuberculosis: a guide to its use in the EU
Drugs & Therapy Perspectives. 2015;31(11):378-384   Crossref logo
Link1 Link2 Link3

Delamanid: A Review of Its Use in Patients with Multidrug-Resistant Tuberculosis
Drugs. 2014;75(1):91-100   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Med has participated in CrossRef Text and Data Mining service since September 11, 2015.